Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| R1 RCM Inc. | 19 | 0 | 0 | 0 | €11.10 | €17.21 | 55.068% |
| Sutro Biopharma Inc | 20 | 0 | 2 | 0 | €3.96 | €11.05 | 179.000% |
| Iovance Biotherapeutics Inc. | 20 | 4 | 1 | 1 | €10.02 | €20.35 | 103.072% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.64 | €174.43 | 16.569% |
| HCA Holdings Inc. | 22 | 0 | 4 | 0 | €297.30 | €296.76 | -0.183% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €16.60 | €28.06 | 69.023% |
| Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €104.20 | €184.92 | 77.466% |
| Humana Inc. | 23 | 0 | 3 | 0 | €319.70 | €439.88 | 37.590% |
| Stryker Corp. | 23 | 0 | 7 | 0 | €300.10 | €335.03 | 11.639% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €156.44 | €200.06 | 27.881% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €61.00 | €79.55 | 30.417% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €286.55 | €297.31 | 3.756% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 4 | 0 | €547.50 | €568.09 | 3.761% |
| Edwards Lifesciences Corp. | 26 | 1 | 4 | 0 | €79.48 | €87.81 | 10.476% |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | €54.50 | €85.64 | 57.144% |
| Merck & Co. Inc. | 28 | 1 | 1 | 0 | €119.20 | €124.92 | 4.801% |
| Tenet Healthcare | 28 | 0 | 5 | 0 | €119.00 | €121.69 | 2.263% |
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | €128.85 | €140.60 | 9.122% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.25 | €40.66 | 54.923% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €140.18 | €196.74 | 40.345% |
| UnitedHealth Group Inc. | 33 | 1 | 2 | 0 | €473.70 | €543.72 | 14.782% |
| Intuitive Surgical Inc | 34 | 0 | 2 | 0 | €355.20 | €370.00 | 4.167% |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 4 | 0 | €913.80 | €959.41 | 4.992% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €137.55 | €236.30 | 71.791% |